![Pia Lindström](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pia Lindström worked as a Director of Regulatory Affairs at Neurocrine Biosciences, Maxim Pharmaceuticals, Kémia, and Quintiles.
She also worked as the VP of Regulatory Affairs and Quality Assurance at Intercept Pharmaceuticals from 2008 to 2012.
Lindström holds a graduate and doctorate degree from The University of North Carolina at Charlotte.
| Companies | Position | End |
|---|---|---|
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | General Counsel | - |
Maxim Pharmaceuticals, Inc.
 Maxim Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs, therapies and vaccines for cancer and infectious diseases | General Counsel | - |
| NEUROCRINE BIOSCIENCES, INC. | General Counsel | - |
Kémia, Inc.
 Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | General Counsel | - |
| INTERCEPT PHARMACEUTICALS, INC. | General Counsel | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Maxim Pharmaceuticals, Inc.
Maxim Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs, therapies and vaccines for cancer and infectious diseases | Health Technology |
Kémia, Inc.
Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
